1. Home
  2. ZVRA vs BVS Comparison

ZVRA vs BVS Comparison

Compare ZVRA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVRA
  • BVS
  • Stock Information
  • Founded
  • ZVRA 2006
  • BVS 2011
  • Country
  • ZVRA United States
  • BVS United States
  • Employees
  • ZVRA N/A
  • BVS N/A
  • Industry
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ZVRA Health Care
  • BVS Health Care
  • Exchange
  • ZVRA Nasdaq
  • BVS Nasdaq
  • Market Cap
  • ZVRA 467.6M
  • BVS 476.3M
  • IPO Year
  • ZVRA 2015
  • BVS 2021
  • Fundamental
  • Price
  • ZVRA $10.12
  • BVS $6.77
  • Analyst Decision
  • ZVRA Strong Buy
  • BVS Strong Buy
  • Analyst Count
  • ZVRA 7
  • BVS 4
  • Target Price
  • ZVRA $22.57
  • BVS $13.75
  • AVG Volume (30 Days)
  • ZVRA 1.8M
  • BVS 217.9K
  • Earning Date
  • ZVRA 11-05-2025
  • BVS 11-04-2025
  • Dividend Yield
  • ZVRA N/A
  • BVS N/A
  • EPS Growth
  • ZVRA N/A
  • BVS N/A
  • EPS
  • ZVRA N/A
  • BVS 0.03
  • Revenue
  • ZVRA $62,020,000.00
  • BVS $564,142,000.00
  • Revenue This Year
  • ZVRA $336.43
  • BVS N/A
  • Revenue Next Year
  • ZVRA $54.26
  • BVS $7.22
  • P/E Ratio
  • ZVRA N/A
  • BVS $244.47
  • Revenue Growth
  • ZVRA 161.81
  • BVS 5.08
  • 52 Week Low
  • ZVRA $6.19
  • BVS $5.81
  • 52 Week High
  • ZVRA $13.16
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • ZVRA 47.05
  • BVS 47.48
  • Support Level
  • ZVRA $10.56
  • BVS $6.66
  • Resistance Level
  • ZVRA $11.23
  • BVS $7.42
  • Average True Range (ATR)
  • ZVRA 0.59
  • BVS 0.27
  • MACD
  • ZVRA -0.09
  • BVS 0.01
  • Stochastic Oscillator
  • ZVRA 3.05
  • BVS 38.07

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: